Erectile Dysfunction Drugs Market Research Report - Forecast till 2027

Erectile Dysfunction Drugs Market Research Report: Information by Drugs (Viagra (sildenafil citrate), Cialis (Tadalafil), Staxyn/Levitra (vardenafil), Stendra/Spedra (avanafil), Zydena (udenafil), Vitaros (Alprostadil Cream)), End User (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2027

ID: MRFR/Pharma/0805-HCR | February, 2021 | Region : Global

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Overview

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

Chapter 6. Global Erectile Dysfunction Drugs Market, by Drug

6.1 Overview

6.2 Viagra (sildenafil citrate)

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3 Cialis (Tadalafil)

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.4 Staxyn/Levitra (vardenafil)

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.5 Stendra/Spedra (avanafil)

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.6 Zydena (udenafil)

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.7 Vitaros (Alprostadil Cream)

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.8 Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 7. Global Erectile Dysfunction Drugs Market, by End User

7 .1 Overview

7 .2 Hospital Pharmacy

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7 .3 Retail Pharmacy

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7 .4 Online Pharmacy

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 8. Global Erectile Dysfunction Drugs Market, by Region

8 .1 Overview

8 .2 Americas

8 .2.1 North America

8 .2.1.1 US

8 .2.1.2 Canada

8 .2.2 Latin America

8 .3 Europe

8 .3.1 Western Europe

8 .3.1.1 Germany

8 .3.1.2 France

8 .3.1.3 Italy

8 .3.1.4 Spain

8 .3.1.5 UK

8 .3.1.6 Rest of Western Europe

8 .3.2 Eastern Europe

8 .4 Asia-Pacific

8 .4.1 Japan

8 .4.2 China

8 .4.3 India

8 .4.4 Australia

8 .4.5 South Korea

8 .4.6 Rest of Asia-Pacific

8 .5 Middle East & Africa

8 .5.1 Middle East

8 .5.2 Africa

Chapter 9. Company Landscape

9.1 Overview

9.2 Competitive Analysis

Chapter 10. Company Profile

10.1 Pfizer, Inc.

10.1.1 Company Overview

10.1.2 Product Type Overview

10.1.3 Financial Overview Overview

10.1.4 Key Developments

10.1.5 SWOT Analysis

10.2 Apricus Biosciences Inc.

10.2.1 Company Overview

10.2.2 Product Type Overview

10.2.3 Financial Overview

10.2.4 Key Developments

10.2.5 SWOT Analysis

10.3 Bayer AG

10.3.1 Company Overview

10.3.2 Product Type Overview

10.3.3 Financial Overview

10.3.4 Key Developments

10.3.5 SWOT Analysis

10.4 Cristalia Produtos Quimicos Farmaceuticos Ltd.

10.4.1 Company Overview

10.4.2 Product Type Overview

10.4.3 Financial Overview

10.4.4 Key Developments

10.4.5 SWOT Analysis

10.5 Dong-A Pharmaceutical Co. Ltd.

10.5.1 Company Overview

10.5.2 Product Type Overview

10.5.3 Financial overview

10.5.4 Key Developments

10.5.5 SWOT Analysis

10.6 Eli Lilly and Company

10.6.1 Company Overview

10.6.2 Product Type Overview

10.6.3 Financial Overview

10.6.4 Key Developments

10.6.5 SWOT Analysis

10.7 Meda Pharmaceuticals, Inc.

10.7 .1 Overview

10.7 .2 Product Type Overview

10.7 .3 Financial Overview

10.7 .4 Key Developments

10.7 .5 SWOT Analysis

10.8 S.K. Chemicals Co. Ltd.

10.8.1 Overview

10.8.2 Product Type Overview

10.8.3 Financial Overview

10.8.4 Key Developments

10.8.5 SWOT Analysis

10.9 Vivus, Inc.

10.9.1 Overview

10.9.2 Product Type Overview

10.9.3 Financial Overview

10.9.4 Key Developments

10.9.5 SWOT Analysis

10.10 Teva Pharmaceutical Industries Ltd.

10.10.1 Overview

10.10.2 Product Type Overview

10.10.3 Financial Overview

10.10.4 Key Developments

10.10.5 SWOT Analysis

10.11 Others

Chapter 11 Appendix

11.1 References

11.2 Related Reports


LIST OF TABLES

Table 1 Global Erectile Dysfunction Drugs Market Synopsis, 2020-2027

Table 2 Global Erectile Dysfunction Drugs Market Estimates and Forecast, 2020-2027 (USD Million)

Table 3 Global Erectile Dysfunction Drugs Market, by Drug, 2020-2027 (USD Million)

Table 4 Global Erectile Dysfunction Drugs Market, by End User, 2020-2027 (USD Million)

Table 5 Global Erectile Dysfunction Drugs Market, by Region, 2020-2027 (USD Million)

Table 6 North America: Erectile Dysfunction Drugs Market, by Drug, 2020-2027 (USD Million)

Table 7 North America: Erectile Dysfunction Drugs Market, by End User, 2020-2027 (USD Million)

Table 8 US: Erectile Dysfunction Drugs Market, by Drug, 2020-2027 (USD Million)

Table 9 US: Erectile Dysfunction Drugs Market, by End User, 2020-2027 (USD Million)

Table 10 Canada: Erectile Dysfunction Drugs Market, by Drug, 2020-2027 (USD Million)

Table 11 Canada: Erectile Dysfunction Drugs Market, by End User, 2020-2027 (USD Million)

Table 12 Latin America: Erectile Dysfunction Drugs Market, by Drug, 2020-2027 (USD Million)

Table 13 Latin America: Erectile Dysfunction Drugs Market, by End User, 2020-2027 (USD Million)

Table 14 Europe: Erectile Dysfunction Drugs Market, by Drug, 2020-2027 (USD Million)

Table 15 Europe: Erectile Dysfunction Drugs Market, by End User, 2020-2027 (USD Million)

Table 16 Western Europe: Erectile Dysfunction Drugs Market, by Drug, 2020-2027 (USD Million)

Table 17 Western Europe: Erectile Dysfunction Drugs Market, by End User, 2020-2027 (USD Million)

Table 18 Eastern Europe: Erectile Dysfunction Drugs Market, by Drug, 2020-2027 (USD Million)

Table 19 Eastern Europe: Erectile Dysfunction Drugs Market, by End User, 2020-2027 (USD Million)

Table 20 Asia-Pacific: Erectile Dysfunction Drugs Market, by Drug, 2020-2027 (USD Million)

Table 21 Asia-Pacific: Erectile Dysfunction Drugs Market, by End User, 2020-2027 (USD Million)

Table 22 Middle East & Africa: Erectile Dysfunction Drugs Market, by Drug, 2020-2027 (USD Million)

Table 23 Middle East & Africa: Erectile Dysfunction Drugs Market, by End User, 2020-2027 (USD Million)  

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Market Structure of the Global Erectile Dysfunction Drugs Market

Figure 3 Market Dynamics of the Global Erectile Dysfunction Drugs Market

Figure 4 Global Erectile Dysfunction Drugs Market Share, by Type, 2020 (%)

Figure 5 Global Erectile Dysfunction Drugs Market Share, by End User, 2020 (%)

Figure 6 Global Erectile Dysfunction Drugs Market Share, by Region, 2020 (%)

Figure 7 North America: Erectile Dysfunction Drugs Market Share, by Country, 2020 (%)

Figure 8 Europe: Erectile Dysfunction Drugs Market Share, by Region, 2020 (%)

Figure 9 Western Europe: Erectile Dysfunction Drugs Market Share, by Country, 2020 (%)

Figure 10 Asia-Pacific: Erectile Dysfunction Drugs Market Share, by Country, 2020 (%)

Figure 11 Middle East & Africa: Erectile Dysfunction Drugs Market Share, by Country, 2020 (%)

Figure 12 Global Erectile Dysfunction Drugs Market: Company Share Analysis, 2020 (%)

Figure 13 Pfizer, Inc.: Key Financial Overview

Figure 14 Pfizer, Inc.: Segmental Revenue

Figure 15 Pfizer, Inc.: Geographic Revenue

Figure 16 Apricus Biosciences Inc.: Key Financial Overview

Figure 17 Apricus Biosciences Inc.: Segmental Revenue

Figure 18 Apricus Biosciences Inc.: Geographic Revenue

Figure 19 Bayer AG: Key Financial Overview

Figure 20 Bayer AG: Segmental Revenue

Figure 21 Bayer AG: Geographic Revenue

Figure 22 Cristalia Produtos Quimicos Farmaceuticos Ltd.: Key Financial Overview

Figure 23 Cristalia Produtos Quimicos Farmaceuticos Ltd.: Segmental Revenue

Figure 24 Cristalia Produtos Quimicos Farmaceuticos Ltd.: Geographic Revenue

Figure 25 Dong-A Pharmaceutical Co. Ltd.: Key Financial Overview

Figure 26 Dong-A Pharmaceutical Co. Ltd.: Segmental Revenue

Figure 27 Dong-A Pharmaceutical Co. Ltd.: Geographic Revenue

Figure 28 Eli Lilly and Company: Key Financial Overview

Figure 29 Eli Lilly and Company: Segmental Revenue

Figure 30 Eli Lilly and Company: Geographic Revenue

Figure 31 Meda Pharmaceuticals, Inc.: Key Financial Overview

Figure 32 Meda Pharmaceuticals, Inc.: Segmental Revenue

Figure 33 Meda Pharmaceuticals, Inc.: Geographic Revenue

Figure 34 S.K. Chemicals Co. Ltd.: Key Financial Overview

Figure 35 S.K. Chemicals Co. Ltd.: Segmental Revenue

Figure 36 S.K. Chemicals Co. Ltd.: Geographic Revenue

Figure 37 Vivus, Inc.: Key Financial Overview

Figure 38 Vivus, Inc.: Segmental Revenue

Figure 39 Vivus, Inc.: Geographic Revenue

Figure 40 Teva Pharmaceutical Industries Ltd.: Key Financial Overview

Figure 41 Teva Pharmaceutical Industries Ltd.: Segmental Revenue

Figure 42 Teva Pharmaceutical Industries Ltd.: Geographic Revenue

Erectile Dysfunction Drugs Market

Erectile Dysfunction (ED) is mainly characterized as constant trouble accomplishing and keeping an erection adequate to have intercourse.

Segmentation

By Drugs Viagra Cialis Stendra/Spedra Zydena Vitaros
By End User Hospital Pharmacy Retail Pharmacy Online Pharmacy

Key Players

  • Pfizer Inc. (U.S)
  • Apricus Biosciences Inc. (U.S).
  • Bayer AG (Germany)
  • Dong–A Pharmaceutical Co. Ltd. (South Korea)
  • S.K. Chemicals Co. Ltd. (South Korea)
  • Eli Lily & Co. (U.S)
  • Apricus Biosciences Inc. (U.S)

Drivers

  • Increasing number of men suffering from this disorder
  • Rising geriatric population
  • Patent expiry of number of blockbuster drugs
Speak to Analyst Request a Free Sample